Unicycive Therapeutics, Inc., (UNCY): Price and Financial Metrics

Unicycive Therapeutics, Inc., (UNCY): $4.58

0.04 (-0.87%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add UNCY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#187 of 309

in industry

UNCY Price/Volume Stats

Current price $4.58 52-week high $11.00
Prev. close $4.62 52-week low $2.02
Day low $4.44 Volume 632,700
Day high $4.72 Avg. volume 354,742
50-day MA $6.03 Dividend yield N/A
200-day MA $5.85 Market Cap 57.90M

UNCY Stock Price Chart Interactive Chart >


Unicycive Therapeutics, Inc., (UNCY) Company Bio


Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.


UNCY Latest News Stream


Event/Time News Detail
Loading, please wait...

UNCY Latest Social Stream


Loading social stream, please wait...

View Full UNCY Social Stream

UNCY Price Returns

1-mo -39.28%
3-mo -23.70%
6-mo -26.13%
1-year -2.97%
3-year -42.79%
5-year N/A
YTD -42.33%
2024 -8.47%
2023 60.69%
2022 -73.79%
2021 N/A
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!